Foresite Capital
Matt Dyer is an accomplished professional with extensive experience in the biotechnology and bioinformatics sectors. Currently serving as a Venture Partner and Executive Advisor at Foresite Labs, as well as a Board Observer at Spear Bio and Pleno Inc., Matt has held various significant roles including Executive Advisor/Investor at Foresite Capital and Owner of CLADE Consulting. Previous positions include Chief Business Officer and Chief Product Officer at Quantum-Si, where strategic initiatives resulted in substantial revenue growth, and Associate Director at Life Technologies, overseeing the development of successful software tools. Matt holds a PhD in Genetics, Bioinformatics, and Computational Biology from Virginia Tech and an MBA from UNC Kenan-Flagler Business School, along with dual degrees in Russian and Bioinformatics from Brigham Young University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Foresite Capital
2 followers
Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $4B in assets under management. The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles.